Legend Capital-backed clinical services provider R&G Pharmastudies floated in a $174m initial public offering while several corporates exited Pymetrics in an acquisition by Harver.
Public markets
Legend Capital, the venture capital firm formed by conglomerate Legend Holdings, has exited China-based contract clinical services provider R&G Pharmastudies in a $174m initial public offering on Shenzhen Stock Exchange’s Chinext market. The firm did not disclosed how much funding it had provided for R&G but said it first invested through a 2017 series A round.
M&A
Recuitment software producer Harver has paid an undisclosed sum to acquire Pymetrics, a US-based skills assessment software provider backed…
